U.S. Pharmaceuticals & Biotech Nano Cap Stocks

Mereo BioPharma Group

Market Cap: US$48.8m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States.

Grace Therapeutics

Market Cap: US$44.6m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

Dyadic International

Market Cap: US$38.3m

A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.

Earth Science Tech

Market Cap: US$30.1m

Together with its subsidies, focuses on health and wellness industry.

Bioqual

Market Cap: US$29.1m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

BioXcel Therapeutics

Market Cap: US$28.8m

Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.

MariMed

Market Cap: US$25.8m

Engages in cultivation, production, and selling of branded cannabis products in the United States.

Jasper Therapeutics

Market Cap: US$25.0m

A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States.

Actinium Pharmaceuticals

Market Cap: US$24.9m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

TherapeuticsMD

Market Cap: US$24.0m

Operates as a pharmaceutical royalty company in the United States and internationally.

MDxHealth

Market Cap: US$22.7m

A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.

Cellectar Biosciences

Market Cap: US$21.1m

A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.

Biofrontera

Market Cap: US$16.0m

A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

PDS Biotechnology

Market Cap: US$14.3m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.

Bio Essence

Market Cap: US$13.5m

Engages in manufacturing and distributing health supplement products.

Pharma-Bio Serv

Market Cap: US$12.4m

Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.

Traws Pharma

Market Cap: US$8.2m

A clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer.

CordovaCann

Market Cap: US$4.4m

Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.

Ayurcann Holdings

Market Cap: US$58.4k

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.

Sunset Island Group

Market Cap: US$34.4k

Through its subsidiary, VBF Brands, grows, cultivates, manufactures, and distributes cannabis in the United States.